PRASUGIL A 75 Prasugrel HCL & Aspirin PRASUGIL A 75 is often prescribed as part of a dual antiplatelet therapy (DAPT) regimen, particularly for patients with acute coronary syndrome (ACS) who are undergoing percutaneous coronary intervention (PCI), such as stent placement. PRASUGIL A 75 aims to reduce the risk of thrombotic cardiovascular events, including stent thrombosis, myocardial infarction (heart attack), and stroke. Prasugrel HCl Prasugrel is a thienopyridine class antiplatelet medication that inhibits platelet activation and aggregation by irreversibly binding to the P2Y12 class of ADP receptors on platelets. It is typically used to prevent clotting events in patients with ACS. Aspirin Aspirin works by inhibiting the enzyme cyclooxygenase (COX), which results in the reduced formation of thromboxane A2, a molecule that encourages platelet aggregation. Aspirin's antiplatelet effect is beneficial in preventing blood clots in arteries. Indications Acute Coronary Syndrome: For patients undergoing angioplasty (PCI) to reduce the risk of cardiovascular death, myocardial infarction, and stroke. Secondary Prevention: In patients with a history of coronary artery disease to prevent future cardiovascular events. For further information: Email: info@sterispharma.com / contact@sterispharma.com Call/WhatsApp: 7877551268, 7849827488 Buy Now: https://www.sterisonline.com/product/prasugil-a-75-134155